Tenet Healthcare Corporation (NYSE:THC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Tenet Healthcare Corporation (NYSE:THC) have received an average rating of “Moderate Buy” from the twenty-two research firms that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, eighteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokers that have covered the stock in the last year is $250.5556.

THC has been the topic of a number of recent research reports. Morgan Stanley restated an “overweight” rating and issued a $260.00 target price on shares of Tenet Healthcare in a report on Thursday, February 12th. Jefferies Financial Group upped their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. UBS Group upped their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Leerink Partners upped their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a report on Friday, February 20th. Finally, Guggenheim upped their target price on shares of Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a report on Thursday, March 12th.

Tenet Healthcare Price Performance

NYSE THC traded down $0.08 during trading hours on Tuesday, reaching $191.18. The company’s stock had a trading volume of 78,708 shares, compared to its average volume of 1,038,885. The stock has a market cap of $16.75 billion, a PE ratio of 12.34, a PEG ratio of 0.95 and a beta of 1.49. Tenet Healthcare has a fifty-two week low of $111.15 and a fifty-two week high of $247.21. The company’s 50-day moving average is $214.15 and its two-hundred day moving average is $205.12. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Analysts forecast that Tenet Healthcare will post 17.3 EPS for the current year.

Insider Transactions at Tenet Healthcare

In other news, EVP Thomas W. Arnst sold 24,000 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares in the company, valued at $1,875,128.48. This represents a 74.97% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 46,517 shares of company stock worth $10,943,111 in the last three months. Company insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of THC. Triumph Capital Management purchased a new position in shares of Tenet Healthcare during the 3rd quarter worth about $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare during the 4th quarter worth approximately $29,000. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare during the 3rd quarter worth approximately $32,000. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.